FDA Approves New HIV Treatment
The U.S. Food and Drug Administration today approved Edurant (rilpivirine) in combination with other antiretroviral drugs for the treatment of HIV-1 infection in adults who have never taken HIV therapy (treatment-naive). Edurant belongs to a class of HIV drugs called non-nucleoside reverse transcriptase inhibitor (NNRTI). The drug works by blocking HIV viral replication. Edurant is to be used as ...

FDA Clears First Test to Diagnose Q Fever in Military Personnel Serving Overseas
SILVER SPRING, Md., May 20, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today cleared the first nucleic acid amplification test to diagnose the early stages of Q fever infections in military personnel serving overseas. The Chemical Biological Medical System Joint Project Management Office within the U.S. Department of Defense funded the development of this test, which ...

FDA Official Sees Drug Approvals Rising
A top agency official said the FDA is seeing a rising number of new drugs ready for approval and expects a gradual increase in medicines that reach the market.